Treatment of Chronic Pelvic Pain Due to Endometriosis by Transcutaneous Auricular Vagus Nerve Stimulation

ConditionEndometriosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age15+
SponsorHopital Foch

About this trial

6-10% of women of childbearing age suffer from endometriosis, which is mainly manifested by dysmenorrhea, non-menstrual pelvic pain and dyspareunia. Several treatment strategies, including surgical ones, are proposed but they are sometimes insufficient because endometriosis-related pain is frequently accompanied by sensitization. Endometriosis surgery, when indicated, is therefore changeably effective, even though the lesions have been completely resected. Patients therefore consult Pain Units seeking for the effective treatment as the pain persist even after surgical management of endometriosis.

Vagus nerve stimulation is a non-invasive technique that includes an anti-inflammatory effect and a modulation of neurotransmitter production (adrenaline, norepinephrine; serotonin, acetylcholine). Yuan and Silberstein published a general review on the technique. Migraine and depression are one of the selected indications. In addition, Napadow et al. published favourable results in a short series of patients with chronic pelvic pain. The Investigators of this study have treated some patients with this technique with a result deemed satisfactory which leads to propose a randomized study to confirm this impression.

Eligibility criteria

Qualifiers

Women aged >= 15 years

With chronic pelvic pain and/ or dysmenorrhoea and/ or dyspareunia

Who has been cared for by a gynecologist in one of the institutions participating in the study

Diagnosed with endometriosis

Disqualifiers

contraindication to the use of transcutaneous auricular vagus nerve stimulation (cardiac pathology, asthmatic patient)

pregnant or breastfeeding women

patient undergoing in vitro fertilization

associated pathology requiring long-term analgesic treatment

Trial design

Treatments tested in this trial

  • Transcutaneous Auricular Vagus Nerve Stimulation

Treatment groups

72 Participants
are divided into 2 treatment groups

Sponsors and collaborators